Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir

Cipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.

from Markets-Economic Times https://ift.tt/2ysohKi